PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
12.54%
Revenue growth at 50-75% of META's 17.47%. Martin Whitman would worry about competitiveness or product relevance.
12.13%
Gross profit growth at 75-90% of META's 16.04%. Bill Ackman would demand operational improvements to match competitor gains.
11.03%
EBIT growth below 50% of META's 24.10%. Michael Burry would suspect deeper competitive or cost structure issues.
11.03%
Operating income growth under 50% of META's 24.10%. Michael Burry would be concerned about deeper cost or sales issues.
5.07%
Net income growth under 50% of META's 21.01%. Michael Burry would suspect the firm is falling well behind a key competitor.
5.73%
EPS growth under 50% of META's 21.33%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
5.81%
Diluted EPS growth under 50% of META's 21.41%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.74%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.74%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-38.30%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-65.06%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
449.10%
10Y revenue/share CAGR under 50% of META's 1437.98%. Michael Burry would suspect a lasting competitive disadvantage.
144.69%
5Y revenue/share CAGR at 75-90% of META's 166.72%. Bill Ackman would encourage strategies to match competitor’s pace.
64.13%
3Y revenue/share CAGR similar to META's 60.93%. Walter Schloss would assume both companies experience comparable short-term cycles.
287.29%
10Y OCF/share CAGR under 50% of META's 1462.36%. Michael Burry would worry about a persistent underperformance in cash creation.
62.17%
Below 50% of META's 184.02%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-9.75%
Negative 3Y OCF/share CAGR while META stands at 55.66%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
557.19%
Below 50% of META's 2571.77%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
157.43%
5Y net income/share CAGR 1.25-1.5x META's 129.08%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
46.99%
3Y net income/share CAGR 1.25-1.5x META's 40.72%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
248.10%
Below 50% of META's 881.35%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
77.64%
5Y equity/share CAGR at 50-75% of META's 104.77%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
37.77%
3Y equity/share CAGR similar to META's 34.47%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
16.93%
AR growth well above META's 24.92%. Michael Burry fears inflated revenue or higher default risk in the near future.
-100.00%
Inventory is declining while META stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.43%
Asset growth well under 50% of META's 6.17%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
4.50%
50-75% of META's 7.62%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
8.25%
Debt growth far above META's 2.81%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
7.59%
R&D growth drastically higher vs. META's 13.81%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
18.98%
SG&A growth well above META's 11.48%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.